INTRODUCTION
For new patients with breast lumps clinicians have concentrated on providing excellent one-stop services, but follow-up breast clinics can leave much to be desired. At worst, large numbers of patients are seen swiftly and inexpertly by a different junior surgical trainee on every visit. The value of follow-up is debatable and the best method is unknownl. Here we describe the first 2 years of a nurse-practitioner-led follow-up breast clinic. METHODS An F-grade nursing sister (YS) underwent a 1-year training in breast examination in a weekly general surgical outpatient clinic. This clinic was run by a consultant surgeon (JJE) with assistance from a senior house officer. During the 2 years of the study, there were 1450 new referrals and 1906 follow-up visits in the clinic. The consultant concerned has specialist interests in both vascular and breast surgery. About one-third of new referrals were for breast disease (audited for 6 months in 1994). 105 new cases of breast cancer were treated by the firm in the two years of the study but some were diagnosed and followed up in community hospital clinics.
An independent breast follow-up clinic was established by the nurse practitioner with the following protocol. The clinic was held only when the consultant surgeon was present in the nearby general surgical clinic. Case notes were reviewed by consultant and nurse practitioner at the start of the clinic. A maximum of 12 patients were seen in a morning session (09OOh-1230h), booked at 15 min intervals. Patients were examined by the nurse practitioner and any abnormal findings were communicated to the consultant. All patients were aware that they were being assessed by a nurse. It was explained to them that they would be reviewed in a nurse-led clinic, at their initial visit for patients with benign disease and at diagnosis or hospital discharge for patients with breast cancer; the nurse practitioner wore nursing uniform in the clinic. All patients were offered a review by the consultant in addition, if they preferred, at each clinic visit. All patients having follow-up for breast cancer were seen by the consultant on alternate visits.
Breast cancer patients were referred to the nursepractitioner-led clinic both preoperatively for counselling, once the diagnosis was established, and postoperatively for follow-up. In addition, some of the preoperative counselling was done outside clinic hours-some in the patients' homes. Patients with early as well as advanced breast cancer were included, though in some patients follow-up was shared with an oncologist. Follow-up after cancer was standard: 3 monthly for 2 years, then 6 monthly until 5 years. Most of the patients diagnosed with benign breast disease who needed follow-up were also included. The policy was to reduce follow-up to a minimum, but most patients with fibrocystic disease had a single follow-up visit.
Prospective records of the clinics have been kept. This report includes results from the first 2 years, 1994 and 1995.
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Procedures performed on patients in the follow-up clinic by the surgeon included fine needle aspiration for cytology (three) or cyst (10) and Trucut biopsy (four). In a follow-up which ranges up to 2.5 years, no significant breast lesion has been missed in this group of patients.
DISCUSSION
The nurse-led breast follow-up clinic was originally designed to increase the throughput of patients but has proved to have many other advantages. The patients see the same person on each clinic visit and are able to form a trusting long-term relationship. Appointments are longer than those in the general clinic and therefore patients with breast cancer can discuss their prosthesis and lymphoedema in addition to their routine follow-up. Any problems with tamoxifen therapy can also be addressed. Patients with benign breast disease can discuss risk factors and hormone replacement therapy. The clinic is a useful place for women with a strong family history of breast cancer to discuss their fears, learn self examination and receive general advice and information about ongoing clinical trials. There is a risk that some breast cancer recurrences will not be detected by the nurse practitioner. This is inevitable if the clinic continues for long enough but is not obviated by clinician follow-up. Contrast the trained nurse practitioner conducting the clinic with an inexperienced senior house officer.
There is debate about the value of follow-up for breast disease and some might argue that many of these patients need not be seen at all. Follow-up of benign breast disease is questionable2, but the policy of the firm was to trim it to a minimum, usually a single appointment only. Though there is doubt about the effectiveness of follow-up for breast cancer3, most surgeons continue to regard it as important4.
The follow-up policy of this firm conforms with published guidelines5. The yield for abnormality in these patients is small and some general practitioners believe the burden of breast follow-up could be transferred to them4'6. Nurse practitioners are becoming established in many branches of medical practice. Their role has yet to be evaluated fully, but follow-up of oncology patients has already been tried elsewhere7. Careful supervision is obviously essential.
That the nurse-led clinic is a cost effective and clinically effective way of conducting breast follow-up will be very hard to prove without a formal scientific comparison. However, our initial favourable experience demonstrates to other surgeons in similar circumstances what can be achieved with little effort other than reorganization of activity. In an era when their wishes are paramount patients have expressed considerable approval of the nursepractitioner-led clinic and as long as follow-up continues to be hospital-based this method is an attractive option for the patients with breast disease.
